Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in helminth-infected patients.
about
Eosinophils in the 1990s: new perspectives on their role in health and diseaseParasitological, Hematological and Biochemical Characteristics of a Model of Hyper-microfilariaemic Loiasis (Loa loa) in the Baboon (Papio anubis)An essential role for interleukin-5 and eosinophils in helminth-induced airway hyperresponsivenessCytokine patterns in the pathogenesis of human leishmaniasis.Trapping and immobilization of Nippostrongylus brasiliensis larvae at the site of inoculation in primary infections of interleukin-5 transgenic mice.Perturbations in eosinophil homeostasis following treatment of lymphatic filariasis.Regulation of global gene expression in human Loa loa infection is a function of chronicity.Interleukin-5 and the posttreatment eosinophilia in patients with onchocerciasis.Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. Cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium.The eosinophilias, including the idiopathic hypereosinophilic syndrome.The interleukin 2 receptor in the hypereosinophilic syndrome.Diethylcarbamazine (DEC): immunopharmacological interactions of an anti-filarial drug.Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples.Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.Experimental infection of a nonhuman primate with Loa loa induces transient strong immune activation followed by peripheral unresponsiveness of helper T cells.Interleukin-5 modulates interleukin-8 secretion in eosinophilic inflammationTransgenic mice in the study of cytokine functionGranulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils.Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists.IL-5 drives eosinophils from bone marrow to blood and tissues in a guinea-pig model of visceral larva migrans syndromeThe role of eosinophils in the pathophysiology of asthma.Eosinophils in health and disease: the LIAR hypothesis.Relevance of ex vivo blood lymphocyte assay for in vivo lymphocyte function.Triple synergism of human T-lymphotropic virus type 1-encoded tax, GATA-binding protein, and AP-1 is required for constitutive expression of the interleukin-5 gene in adult T-cell leukemia cells.Biological activities of hematopoietic growth factors that lead to future clinical application.Growth factors of the future.The biology of interleukin-5 and its receptor.Eosinophilia associated with clonal T-cell proliferation.Expression of interleukin-5 and granulocyte-macrophage colony-stimulating factor in human peripheral blood mononuclear cells after activation with phorbol myristate acetate.Comparison of immune responses in mice infected with different strains of Strongyloides venezuelensis.In vivo evidence for a non-T cell origin of interleukin-5.The effect of T-cell depletion on enhanced basophil histamine release after in vitro incubation with live influenza A virus.Cytokines in the modulation of eosinophilia.The infectivity and antigenicity of Toxocara canis eggs can be retained after long-term preservation.Soluble CD23 and IL-5 levels in the serum and culture supernatants of peripheral blood mononuclear cells in a girl with cutaneous paragonimiasis: case report.Elevated IL-5 levels in pleural fluid of patients with paragonimiasis westermani
P2860
Q24648898-1A508479-9C63-4672-A89B-E5CB8F816FD2Q28550781-AE1CEBEE-50ED-466E-AB35-DFBF4636F36DQ33762876-82F4D04E-A072-4544-B4AD-9DB8178D14B5Q33895266-712BCFA7-2604-4DAC-8619-EE86F7DE4B21Q34002145-6BAD35DD-DB02-4EBA-9ACB-54EBD3091B37Q34002965-A3164898-8B4B-4503-83EE-07640BA368F2Q34184728-D8AE883E-E54E-421B-976B-5584EFCC6800Q34205792-04AF6317-0441-4642-AB94-BE965B06F4B0Q34214952-BDC33FE5-8EEE-417D-8722-B41BC5BEE253Q35106674-70455CA0-DB09-4D69-AFDE-05C062E7C66AQ35219348-ED295C61-D1EE-4171-BF05-0EA37337B153Q35224455-AD0ACD78-416D-4205-AC94-0547F1C6F185Q35348875-CCB2F14B-0934-4F4F-BCA1-150B53961C8AQ35372676-79A5A197-FF46-4A89-B546-4A2190794FACQ35547137-E229159F-84C5-42EC-A2EF-AE9ECFCADE7CQ35609812-6431A439-1B6E-4982-BB68-5A223846C01EQ36029215-6EEF0860-9582-4524-8F9F-DD3683C9D841Q36230348-B472D3A4-8BB5-4725-95F7-3749CFFB8408Q36354173-1D3C0215-8C9A-4E23-AA9B-0A4E214C54CDQ36628083-531041E1-3922-4ECD-BB65-27F2885B459BQ36696971-32C1AEE1-80E4-4E84-8E0B-28463896544DQ37743621-D12B7104-DAC3-44E3-8DD3-AD58212B6C2AQ38920054-FCF589A1-F01B-4E4D-BD84-F3C60BBE59C1Q40022833-CB65F77F-17A6-4D2C-B88F-39CD49095F14Q40630439-4DEDF574-50CB-40AF-9001-FF1CB004B75CQ40833043-EAAC6E2A-1099-4FD5-9ADB-D0638B356E02Q40860972-CD7F9441-3F66-416C-A226-A77DEF893833Q41663800-F2A789F1-FB32-4B72-874A-B7672D72F0E3Q41853304-977A8DA9-D04A-49CB-B906-BCC6D2A6B3B7Q43223338-B65BA4B2-DE75-4C6D-9BBF-FAD3903893A1Q43532287-0CA96F2F-2B72-47BB-93C5-0C1491CCB7CBQ44292149-B3742797-2770-4D22-860B-F55CE768624DQ46818901-1CFCEDDE-BEEF-461B-AC53-21A8D8DE13E9Q47668364-F9E44C35-B516-47CE-8C7D-0DE3802DFC6DQ47736609-A8629FF7-5E2D-4B70-9D54-F0432C31BC72Q57646125-4C89FBB6-B56D-453B-A92D-6335BB251BA8
P2860
Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in helminth-infected patients.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Regulation of parasite-induced ...... in helminth-infected patients.
@ast
Regulation of parasite-induced ...... in helminth-infected patients.
@en
type
label
Regulation of parasite-induced ...... in helminth-infected patients.
@ast
Regulation of parasite-induced ...... in helminth-infected patients.
@en
prefLabel
Regulation of parasite-induced ...... in helminth-infected patients.
@ast
Regulation of parasite-induced ...... in helminth-infected patients.
@en
P2093
P2860
P356
P1476
Regulation of parasite-induced ...... in helminth-infected patients.
@en
P2093
P2860
P304
P356
10.1084/JEM.172.1.399
P407
P577
1990-07-01T00:00:00Z